{'text': "Don't Underestimate Amgen: Part 2A, Cardiovascular And Oncology Pipeline Products (NASDAQ:AMGN)", 'publisher': {'href': 'https://seekingalpha.com', 'title': 'Seeking Alpha'}, 'created_at': 'Wed, 29 Jan 2014 08:00:00 GMT', 'description': "Don't Underestimate Amgen: Part 2A, Cardiovascular And Oncology Pipeline Products (NASDAQ:AMGN)  Seeking Alpha", 'url': 'https://news.google.com/rss/articles/CBMiuwFBVV95cUxOczNHU2tzR01IcTBqNTRoVl9EdW1IS05XX1k1a2RmYm44VGhKMUNlbml3N2NoWWl5UTBsZER0VUZwWXdOZXloT2dtaElnLTFPeEFTOUV6MWxyeFFQZjRiVVllc3V5ZzBvOS1uWDlzQkRWVUhRbldOV01ZUnQ5MzJiczE2emFnTnZWRXJKUHp1X0pLTmpSRnFKTXNEM2E2NFlVYWpDTjRyMGExVGZxR2ZOVWFuMlo5X0plcFdR?oc=5&hl=en-US&gl=US&ceid=US:en'}
